NeuBase Therapeutics, Inc. (NBSE) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for NeuBase Therapeutics, Inc., with annual and quarterly history.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.37x | -3.84x | -8.63x | -1.52x | -0.82x | -1.35x |
| P/B Ratio | 0.55x | 1.82x | 4.76x | 4.12x | 0.99x | 1.41x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 5.92x | 13.10x | 10.42x | 4.41x | 5.52x | 2.64x |
| Quick Ratio | 5.95x | 13.10x | 10.42x | 4.41x | 5.52x | 2.64x |
| Leverage | ||||||
| Debt/Equity | 0.26x | 0.12x | 0.00x | 0.01x | 0.01x | 0.00x |
YoY = year-over-year change. Source: FMP..